Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biodistribution, Metabolism and Excretion of [18F]Fluotriopride in Healthy Volunteers
NCT02379338Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- Mar 2015
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [18F]fluortriopride (2 cohorts), sponsored by University of Pennsylvania. Primary endpoints: Biodistribution and Human Dosimetry at 1 week and Feasibility of imaging the brain at 1 week. Started Mar 2015; status: completed.
02
Drugs
[18F]fluortriopride
Beyond the preview
Go deeper on NCT02379338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379338.